Business News

Octillion Announces Appointment of Mr. Joseph Sierchio, Esq. to Board of Directors

2008-07-24 11:22:00

Octillion Announces Appointment of Mr. Joseph Sierchio, Esq. to Board of Directors

AUBURN HILLS, Mich.–(EMWNews)–Octillion Corp. (OTCBB:OCTL), a next-generation alternative and

renewable energy technology incubator, today announced the appointment

of Mr. Joseph Sierchio, Esq., an attorney with over three decades of

experience in corporate finance and securities law, to the Companys

Board of Directors.

Mr. Joseph Sierchio earned his Doctor of Law degree at Cornell

University Law School in 1974, and a Bachelor of Arts degree, with

Highest Distinction in Economics, from Rutgers College at Rutgers

University, in 1971.

Mr. Sierchio brings us 33 years of experience

in the aspects of corporate law that are most relevant to a public

company like Octillion, stated Mr. Nicholas

Cucinelli, President and CEO of Octillion Corp. Joes

hands-on expertise with regulatory compliance, mergers and acquisitions,

and institutional financing, as well as his considerable experience in

the alternative energy sector, make for a welcome addition to our Board.

Since 1975, Mr. Joseph Sierchio has practiced corporate and securities

law in New York City, representing and offering counsel to domestic and

foreign corporations, investors, entrepreneurs, and public and private

companies in the United States, Canada, United Kingdom, Germany, Italy,

Switzerland, Australia, and Hong Kong. Mr. Sierchio is admitted in all

New York state courts and federal courts in the Eastern, Northern, and

Southern Districts of the State of New York as well as the federal Court

of Appeals for the Second Circuit. Mr. Sierchio is also a member of

Sierchio & Company, LLP, counsel to the Company.

About Octillion Corp.

Octillion Corp., together with its wholly owned subsidiaries, is a next

generation technology incubator focused on the identification,

acquisition, development, and commercialization of alternative and

renewable energy technologies.

Through established relationships with universities, research

institutions, government agencies, and start-up companies, we strive to

identify technologies and business opportunities on the leading edge of

innovation that have the potential of serving significant and unmet

market needs.

Once a technology has been identified, we fund the research and

development activities relating to the technology with the intention of

ultimately, if warranted, licensing, commercializing and marketing the

subject technology, either through internal resources, collaborative

agreements or otherwise.

Unique to our business model is the use of established research

infrastructure owned by the various organizations we work with, saving

us significant capital which would otherwise be required for such things

as land and building acquisition, equipment and furniture purchases, and

other incidental start up costs. As a result, we are able to benefit

from leading edge research and development while employing significantly

less capital than conventional organizations.

Among our current research and development activities is the development

of a technology that could adapt existing home and office glass windows

into ones capable of generating electricity from solar energy without

losing significant transparency or requiring major changes in

manufacturing infrastructure.

The technological potential of adapting existing glass windows into ones

capable of generating electricity from the suns

solar energy has been made possible through a ground breaking discovery

of an electrochemical and ultrasound process that produces identically

sized (1 to 4 nanometers in diameter) highly luminescent nanoparticles

of silicon that provide varying wavelengths of photoluminescence with

high quantum down conversion efficiency of short wavelengths (50% to

60%).

When thin films of silicon nanoparticles are deposited (sprayed) onto

silicon substrates, ultraviolet light is absorbed and converted into

electrical current. With appropriate connections, the films act as

nanosilicon photovoltaic solar cells that convert solar radiation to

electrical energy.

We are also developing a system to harness the kinetic energy of

vehicles in motion as part of a broader effort to enhance the

sustainability and energy efficiency of transportation infrastructures

and systems.

For additional information, please visit: www.octillioncorp.com

To receive future press releases via email, please visit:

http://www.octillioncorp.com/contact.html

To view the full HTML text of this release, please visit:

http://Octillioncorp.com/OCTL_20080724.html

Legal Notice Regarding Forward-Looking

Statements

No statement herein should be considered an offer or a solicitation of

an offer for the purchase or sale of any securities. This release

contains forward-looking statements that are based upon current

expectations or beliefs, as well as a number of assumptions about future

events. Although Octillion Corp. (the Company

or Octillion)

believes that the expectations reflected in the forward-looking

statements and the assumptions upon which they are based are reasonable,

it can give no assurance that such expectations and assumptions will

prove to have been correct. Forward-looking statements, which involve

assumptions and describe our future plans, strategies, and expectations,

are generally identifiable by use of the words may,

will, should,

could, expect,

anticipate, estimate,

believe, intend,

or project or

the negative of these words or other variations on these words or

comparable terminology. The reader is cautioned not to put undue

reliance on these forward-looking statements, as these statements are

subject to numerous factors and uncertainties, including but not limited

to adverse economic conditions, intense competition, lack of meaningful

research results, entry of new competitors and products, adverse

federal, state and local government regulation, inadequate capital,

unexpected costs and operating deficits, increases in general and

administrative costs, termination of contracts or agreements,

technological obsolescence of the Company’s products, technical problems

with the Company’s research and products, price increases for supplies

and components, litigation and administrative proceedings involving the

Company, the possible acquisition of new businesses or technologies that

result in operating losses or that do not perform as anticipated,

unanticipated losses, the possible fluctuation and volatility of the

Company’s operating results, financial condition and stock price, losses

incurred in litigating and settling cases, dilution in the Company’s

ownership of its business, adverse publicity and news coverage,

inability to carry out research, development and commercialization

plans, loss or retirement of key executives and research scientists,

changes in interest rates, inflationary factors, and other specific

risks. We currently have no commercial products intended to diagnose,

treat, prevent or cure any disease. The statements contained in this

press release regarding our on going research and development and the

results attained by us to-date have not been evaluated by the Food and

Drug Administration. There can be no assurance that further research and

development, and /or whether clinical trial results, if any, will

validate and support the results of our preliminary research and

studies. Further, there can be no assurance that the necessary

regulatory approvals will be obtained or that Octillion will be able to

develop commercially viable products on the basis of its technologies.

In addition, other factors that could cause actual results to differ

materially are discussed in the Company’s most recent Form 10-QSB and

Form 10-KSB filings with the Securities and Exchange Commission. These

reports and filings may be inspected and copied at the Public Reference

Room maintained by the U.S. Securities & Exchange Commission at 100 F

Street, N.E., Washington, D.C. 20549. You can obtain information about

operation of the Public Reference Room by calling the U.S. Securities &

Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange

Commission also maintains an Internet site that contains reports, proxy

and information statements, and other information regarding issuers that

file electronically with the U.S. Securities & Exchange Commission at http://www.sec.gov.

The Company undertakes no obligation to publicly release the results of

any revisions to these forward looking statements that may be made to

reflect the events or circumstances after the date hereof or to reflect

the occurrence of unanticipated events.

Octillion Corp.
Mr. Nicholas S. Cucinelli, 800-213-0689
www.octillioncorp.com

free cash grants, free grant money, free money, cash grants, scholarships, business grants, foundation grants, government grants, debt grants, consolidation, college tuition, financial aid, medical grants, personal grants, medical bills, unsecured loans, no interest loans, financing, loans, capital, non profit organizations

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions





























Jordan Taylor

Jordan Taylor is Sr. Editor & writer from San Diego, CA. With over 20 years and 2650+ articles edited rest assured your Press Release will see traction.

Related Articles

Back to top button